Brain-Training Exercises for Long COVID
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether brain-training exercises can help older adults with Long COVID. Researchers aim to determine if these computer-based activities can enhance memory, mood, and daily functioning for individuals with ongoing cognitive issues after recovering from COVID-19. The treatment under investigation is called NeuroFlex. Suitable participants are those aged 60 or older who experience lingering cognitive symptoms after COVID-19 that impact their daily life. As an unphased trial, this study provides a unique opportunity to contribute to understanding how brain-training might aid recovery from Long COVID.
Will I have to stop taking my current medications?
The trial requires that if you are on psychiatric medications, you must be on a stable dose for at least 1 month before starting the study and have no plans to change the dose during the study.
What prior data suggests that these brain-training exercises are safe for older adults with Long COVID?
Research shows that computerized brain-training exercises, like those used in NeuroFlex, are generally easy for people to handle. Studies on similar activities have found they usually don't cause serious side effects. Often compared to video games, these exercises are designed to be fun and safe. Participants might experience mild issues, such as eye strain or tiredness, but these are typically temporary. Past studies with similar brain-training programs have reported no major problems. Thus, current evidence suggests that NeuroFlex is likely a safe choice for most people.12345
Why are researchers excited about this trial?
NeuroFlex is unique because it uses computerized cognitive remediation to tackle the lingering cognitive issues of Long COVID. Unlike traditional treatments that often focus on symptom management, like medication or physical therapy, NeuroFlex directly targets brain function through interactive brain-training exercises. Researchers are excited because this approach could enhance cognitive flexibility and memory, offering a non-invasive, engaging, and potentially more effective way to improve mental clarity and quality of life for Long COVID patients.
What evidence suggests that NeuroFlex might be an effective treatment for Long COVID?
Research has shown that computer-based brain exercises might help older adults with Long COVID feel better. These exercises improve thinking skills like memory and focus, which Long COVID often affects. Some studies suggest that brain-training can also boost mood and overall quality of life for those with these symptoms. While specific proof for brain-training's effect on Long COVID is still developing, its success in addressing other health issues suggests it could be useful. Early results from this trial, which includes a treatment arm using Computerized Cognitive Remediation, indicate these exercises might help manage Long COVID symptoms.16789
Who Is on the Research Team?
Cutter Lindbergh, Ph.D.
Principal Investigator
UConn Health
Are You a Good Fit for This Trial?
This trial is for older adults (55+) who've had COVID-19 and are experiencing ongoing cognitive symptoms that started after their illness. They should be fluent in English, have a certain level of cognitive function (TICS ≥ 27), and not planning to change any psychiatric medication doses during the study. People with neurological disorders, prior cognitive impairments unrelated to COVID-19, significant psychiatric conditions, recent substance use disorders, or major sensory/motor issues can't participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo computerized brain-training exercises to treat Long COVID symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- NeuroFlex
Find a Clinic Near You
Who Is Running the Clinical Trial?
UConn Health
Lead Sponsor
National Institute on Aging (NIA)
Collaborator